[1] 杨彦麟,肖萍,高鹏,等.阿德福韦酯联合拉米夫定治疗慢性乙型肝炎病毒耐药分析.临床荟萃,2012,27:1852-1855.
[2] 钟石英,曾伟强,邓小梅.干扰素与阿德福韦酯治疗慢性乙型肝炎的效果比较.实用医学杂志,2011,27:2644-2645.
[3] Perrillo RP,Hann HW,Schiff E,et al.Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.Hepatol Int,2011,5:654-663.
[4] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).肝脏,2011,16:2-16.
[5] Ikeda F,Baba N,Takaguchi K,et al.Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine:a 5-year study of patients with hepatitis B with lamivudine resistance.J Med Virol,2012,84:1562-1570.
[6] Fan XH,Geng JZ,Wang LF,et al.De novo combination therapy with lamivudine and adefovir dipivoxil in chronic heoatitis B patients.World J Gastroenterol,2011,17:4804-4809.
[7] 庄辉,翁心华.核苷和核苷酸类药物治疗慢性乙型肝炎的耐药及其管理.肝脏,2013,17:1-10.
[8] 李芳,雷飞飞,李刚,等.拉米夫定和阿德福韦酯初始联合治疗慢性乙型肝炎的临床研究.药物与临床,2012,21:85-86.
[9] 李芳,雷飞飞,李刚,等.拉米夫定和阿德福韦酯初始联合治疗慢性乙型肝炎的临床研究.中国医药导报,2012,9:85-86.
[10] 任娜,闫杰,蔡皓东,等.拉米夫定与阿德福韦酯初始联合治疗HBe Ag阳性慢性乙型肝炎96周疗效观察.国际病毒学杂志,2012,19:113-117.
[11] Ghany MG,Feld JJ,Zhao X,et al.Randomised clinical trial:the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B.Aliment Pharmacol Ther,2012,35:1027-1035. |
